Company / Operating Cash Flow
RIGEL PHARMACEUTICALS INC Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$75.7M
FY2025
5-year range
-$73.8M / $75.7M
FY2021-FY2025
Trend
+140.4%
vs FY2024
Sector context
#55 of 216
Health Care
What the data says
RIGEL PHARMACEUTICALS INC's operating cash flow of $76M is higher than 75% of companies in the Health Care sector (FY2025). Operating Cash Flow has increased for 3 consecutive years, from -$74M in FY2022 to $76M in FY2025.
Based on SEC 10-K filings.
$76M in FY2025.
Improved from -$6M to $76M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 216This company $75.7M Sector average $659.0M
▼
-88.5% below sector average
Key checks
Key Insights
- RIGEL PHARMACEUTICALS INC's operating cash flow has grown for 3 consecutive years.
- In FY2025, operating cash flow increased 140.4% year-over-year.
- Ranks #55 out of 216 companies in the Health Care sector.
- Lowest operating cash flow in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $75.7M | +140.4% |
| FY2024 | $31.5M | +648.0% |
| FY2023 | -$5.7M | +92.2% |
| FY2022 | -$73.8M | -1354.8% |
| FY2021 | $5.9M | +111.3% |
| FY2020 | -$52.2M | -25.7% |
| FY2019 | -$41.5M | +45.3% |
| FY2018 | -$75.9M | +2.2% |
| FY2017 | -$77.6M | -2.2% |
| FY2016 | -$75.9M | -224.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026